Regenxbio Inc
NASDAQ:RGNX

  • LAST PRICE
    13.1200
  • TODAY'S CHANGE (%)
    -0.4600 (-3.3873%)
  • Bid / Lots
    13.1000/ 4
  • Ask / Lots
    13.1800/ 4
  • Open / Previous Close
    13.7400 / 13.5800
  • Day Range
    12.9000
    13.8400
  • 52 Week Range
    11.8300
    28.8000
  • Volume
    227,066

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Today

      Show headlines and story abstract

    • 2 hours ago by MT Newswires
      Companies Mentioned: RGNX
      08:07 AM EDT, 06/12/2024 (MT Newswires) -- Regenxbio (RGNX) said Wednesday it named Chief Operating Officer Curran Simpson as president, chief executive and a member of the board, effective July 1. Simpson joined the company in 2015 as chief technol...

    • 3 hours ago by Dow Jones
      Companies Mentioned: RGNX

      By Dean Seal

      Regenxbio has tapped Curran Simpson, its operations chief, to take over as Chief Executive Officer from co-founder Kenneth Mills, who is moving from the C-suite to the role of board chairman.

    • 3 hours ago by PR Newswire
      Companies Mentioned: RGNX

      -- Curran Simpson, Chief Operating Officer, Appointed as President and CEO

      -- Co-Founder KennethT. Mills to Step Down as President and CEO; Named Chairman of the Board

      REGENXBIO Inc. (Nasdaq: RGNX) today announced that Curran Simpson, Chief Operating Officer, has been appointed as President, Chief Executive Officer and a member of the Board of Directors, effective July 1, 2024. Co-Founder Kenneth T. Mills will step down as President and Chief Executive Officer following 15 years of leadership at the Company, and he is taking on an expanded role on the Board as Chairman. In connection with these changes, Board member Daniel Tassé has been appointed as REGENXBIO's Lead Independent Director, a role previously held by Jerry Karabelas, Ph.D. Dr. Karabelas and Co-Founder Allan Fox, who has served as Chairman since 2020, will remain on the Board.

    • 3 hours ago by Dow Jones
      Companies Mentioned: RGNX

      REGENXBIO Announces Leadership Transition

      PR Newswire

      ROCKVILLE, Md., June 12, 2024
      -- Curran Simpson, Chief Operating Officer, Appointed as President and CEO -- Co-Founder Kenneth T. Mills to Step Down as President and CEO; Named Chairman of the Board

    • 3 hours ago by Dow Jones
      Companies Mentioned: RGNX

      REGENXBIO Announces Leadership Transition

      PR Newswire

      ROCKVILLE, Md., June 12, 2024
      -- Curran Simpson, Chief Operating Officer, Appointed as President and CEO -- Co-Founder Kenneth T. Mills to Step Down as President and CEO; Named Chairman of the Board

Peers Headlines